SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008385
Filing Date
2020-05-12
Accepted
2020-05-12 16:41:19
Documents
84
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 595429
2 ex10-3.htm EX-10.3 5680
3 ex31.htm EX-31 34808
4 ex32.htm EX-32 8525
5 ex10-3_001.jpg GRAPHIC 138754
6 ex10-3_002.jpg GRAPHIC 293291
7 ex10-3_003.jpg GRAPHIC 308603
8 ex10-3_004.jpg GRAPHIC 143036
9 ex10-3_005.jpg GRAPHIC 119822
10 ex10-3_006.jpg GRAPHIC 144778
  Complete submission text file 0001493152-20-008385.txt   6264444

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE ocx-20200331.xml EX-101.INS 768139
12 XBRL SCHEMA FILE ocx-20200331.xsd EX-101.SCH 70473
13 XBRL CALCULATION FILE ocx-20200331_cal.xml EX-101.CAL 84994
14 XBRL DEFINITION FILE ocx-20200331_def.xml EX-101.DEF 217848
15 XBRL LABEL FILE ocx-20200331_lab.xml EX-101.LAB 453475
16 XBRL PRESENTATION FILE ocx-20200331_pre.xml EX-101.PRE 336833
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 20869660
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences